WHO approves infant-specific malaria treatment, a landmark for child health
The World Health Organization has prequalified Coartem Baby, the first malaria treatment designed for infants as small as 2 kg, enabling public-sector use globally; developed by Novartis and MMV, it aims to reduce dosing errors and toxicity and has begun rollout in Ghana with plans to expand across sub-Saharan Africa.